Stocks Declined: Ariad Pharmaceuticals, ARM Holdings plc, Freescale Semiconductor Ltd, ZIOPHARM Oncology Inc

Dallas, TX -- (SBWIRE) -- 03/22/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares dropped 3.62% to $19.71. The company announced its schedule of preclinical data presentations to be made at the American Association for Cancer Research (AACR) Annual Meeting 2013, taking place Saturday, April 6 through Wednesday, April 10, 2013, in Washington.

How Should Investors Trade ARIA After The Recent Price movement? Find out Here

ARM Holdings plc (ADR)(NASDAQ:ARMH) shares decreased 3.59% to $39.72 in the last trading session. Dow Jones on Mar. 19 reported that ARM Holdings plc said that Chief Executive Officer (CEO) Warren East has decided to retire from the Company, effective July 1, and it has appointed Simon Segars as his successor. The company designs microprocessors, physical intellectual property (IP) and related technology and software, and sells development tools.

Is ARMH a Strong Buying Opportunity After The Recent Slump? Find out Here

Freescale Semiconductor Ltd (NYSE:FSL) shares fell 3.59% and closed at $14.52. The company, on Mar. 4, announced that effective March 1, 2013, it obtained new senior secured term loan facilities pursuant to an amendment and restatement of the company's senior secured credit facility. The new credit facility provides for two term loan tranches in an aggregate principal amount of approximately $2.74 billion, consisting of a $350 million term loan that will mature in December 2016 and a $2.39 billion term loan that will mature in March 2020.

Is FSL a Buy After The Latest Price Action? Find Out Here

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) shares declined 3.56% to $5.14. The company, on Mar. 18, reported fourth-quarter net loss of $30.2 million or $0.37 per share, wider than $13.2 million or $0.19 per share reported last year. Adjusted net loss was $38.8 million or $0.48 per share compared to $16.4 million or $0.24 per share last year. Analysts estimated loss of $0.29 per share for the quarter. Revenues for the quarter were $200 thousand, flat with last year. Analysts estimated sales of $170 thousand for the quarter.

Is ZIOP a Buy After The Latest Price Action? Find Out Here

About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com

Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.